Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying tumor antigens and immuno‐subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccine

20 May 2022

Abstract excerpt

The mRNA vaccine has provided a promising approach for cancer immunotherapies. However, only a few mRNA vaccines have been developed against colon adenocarcinoma (COAD). Screening potential targets for mRNA vaccines from numerous candidates is a substantial challenge. Considering the tumor heterogeneity, only a subset of patients might respond to vaccinations. This study was conducted to identify potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immunotherapy and Immune Responses
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35593226
DOI: 10.1002/cam4.4846

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying tumor antigens and immuno‐subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccinePMID 35593226Read ↗

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.Semantic proximity Read ↗

Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune SubtypeSemantic proximity Read ↗

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA VaccinationSemantic proximity Read ↗

How Can We Improve Subtyping of Colon Adenocarcinoma for Precision Oncology? Multi-Omics Consensus Clustering Reveals Immunologically Active and Therapeutically Distinct Molecular Groups.Semantic proximity Read ↗

Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy ResponsesSemantic proximity Read ↗

Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanismsSemantic proximity Read ↗

Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysisSemantic proximity Read ↗

Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon AdenocarcinomaSemantic proximity Read ↗

Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma.Semantic proximity Read ↗

Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanismsSemantic proximity Read ↗

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccineSemantic proximity Read ↗

Immunogenomic Classification of Colorectal Cancer and Therapeutic ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.